MP0250

· Molecular Partners AG

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MP0250, covering 2019-08-07 to 2021-08-25. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 2 Trial of MP0250 Plus Bortezomib + Dexamethasone in Patients With Multiple Myeloma [Phase 1, Phase 2]